中達集團控股(00139.HK):賣方就收購進鴻支付按金5200萬港元
格隆匯2月28日丨中達集團控股(00139.HK)發佈公告,有關建議出售進鴻有限公司的全部已發行股本及股東貸款。2020年2月28日,買方已根據初步買賣協議向賣方律師(作為保管人)支付進一步按金合共5200萬港元。
此外,如第此前披露,賣方與買方須於2020年2月28日或之前訂立正式協議。由於賣方及買方仍在就正式協議條款進行磋商,故雙方尚未在2020年2月28日或之前籤立正式協議。根據初步買賣協議條款,初步買賣協議仍然有效,而初步買賣協議的訂約方須繼續履行各自據此承擔的責任。倘籤立正式協議,則公司將按照上市規則另行發出公告。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.